{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T22:08:36Z","timestamp":1790287716203,"version":"4.1.0"},"reference-count":31,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2018,10,27]],"date-time":"2018-10-27T00:00:00Z","timestamp":1540598400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"name":"Research Grants for Intractable Diseases from the Japanese Ministry of Health, Labor, and Welfare","award":["H21-061"],"award-info":[{"award-number":["H21-061"]}]},{"name":"Research Grants for Intractable Diseases from the Japanese Ministry of Health, Labor, and Welfare","award":["H24-025"],"award-info":[{"award-number":["H24-025"]}]},{"name":"Research Grants for Intractable Diseases from the Japanese Ministry of Health, Labor, and Welfare","award":["H23-012"],"award-info":[{"award-number":["H23-012"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Ann Hematol"],"published-print":{"date-parts":[[2019,2]]},"DOI":"10.1007\/s00277-018-3517-0","type":"journal-article","created":{"date-parts":[[2018,10,27]],"date-time":"2018-10-27T09:24:42Z","timestamp":1540632282000},"page":"271-280","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":19,"title":["Associations of complementation group, ALDH2 genotype, and clonal abnormalities with hematological outcome in Japanese patients with Fanconi anemia"],"prefix":"10.1007","volume":"98","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-0697-5506","authenticated-orcid":false,"given":"Miharu","family":"Yabe","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takashi","family":"Koike","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Keisuke","family":"Ohtsubo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eri","family":"Imai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tsuyoshi","family":"Morimoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiromitsu","family":"Takakura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katsuyoshi","family":"Koh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kenichi","family":"Yoshida","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seishi","family":"Ogawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Etsuro","family":"Ito","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yusuke","family":"Okuno","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hideki","family":"Muramatsu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seiji","family":"Kojima","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Keitaro","family":"Matsuo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Minako","family":"Mori","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Asuka","family":"Hira","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Minoru","family":"Takata","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiromasa","family":"Yabe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2018,10,27]]},"reference":[{"key":"3517_CR1","doi-asserted-by":"publisher","first-page":"1249","DOI":"10.1182\/blood-2002-07-2170","volume":"101","author":"DI Kutler","year":"2003","unstructured":"Kutler DI, Singh B, Satagopan J, Batish SD, Berwick M, Giampietro PF, Hanenberg H, Auerbach AD (2003) A 20-year perspective on the International Fanconi Anemia Registry (IFAR). Blood 101:1249\u20131256. \n                    https:\/\/doi.org\/10.1182\/blood-2002-07-2170","journal-title":"Blood"},{"key":"3517_CR2","doi-asserted-by":"publisher","first-page":"3013","DOI":"10.1172\/JCI92069","volume":"127","author":"K Knies","year":"2017","unstructured":"Knies K, Inano S, Ram\u00edrez MJ, Ishiai M, Surrall\u00e9s J, Takata M, Schindler D (2017) Biallelic mutations in the ubiquitin ligase RFWD3 cause Fanconi anemia. J Clin Invest 127:3013\u20133027. \n                    https:\/\/doi.org\/10.1172\/JCI92069","journal-title":"J Clin Invest"},{"key":"3517_CR3","first-page":"4064","volume":"96","author":"L Faivre","year":"2000","unstructured":"Faivre L, Guardiola P, Lewis C et al (2000) Association of complementation group and mutation type with clinical outcome in Fanconi anemia. Blood 96:4064\u20134070","journal-title":"Blood"},{"key":"3517_CR4","doi-asserted-by":"publisher","first-page":"180","DOI":"10.1016\/j.cancergencyto.2010.07.127","volume":"203","author":"PA Mehta","year":"2010","unstructured":"Mehta PA, Harris RE, Davies SM et al (2010) Numerical chromosomal changes and risk of development of myelodysplastic syndrome\u2014acute myeloid leukemia in patients with Fanconi anemia. Cancer Genet Cytogenet 203:180\u2013186. \n                    https:\/\/doi.org\/10.1016\/j.cancergencyto.2010.07.127","journal-title":"Cancer Genet Cytogenet"},{"key":"3517_CR5","doi-asserted-by":"publisher","first-page":"3872","DOI":"10.1182\/blood-2002-10-3243","volume":"101","author":"H Tonnies","year":"2003","unstructured":"Tonnies H, Huber S, Kuhl JS, Gerlach A, Ebell W, Neitzel H (2003) Clonal chromosomal aberrations in bone marrow cells of Fanconi anemia patients: gains of chromosomal segment 3q26q29 as an adverse risk factor. Blood 101:3872\u20133874. \n                    https:\/\/doi.org\/10.1182\/blood-2002-10-3243","journal-title":"Blood"},{"key":"3517_CR6","doi-asserted-by":"publisher","first-page":"e161","DOI":"10.1182\/blood-2010-09-308726","volume":"117","author":"S Quentim","year":"2011","unstructured":"Quentim S, Cuccuini W, Ceccldi R et al (2011) Myelodysplasia and leukemia of Fanconi anemia are associated with a specific pattern of genomic abnormalities that includes cryptic RUNX1\/AML1 lesions. Blood 117:e161\u2013e170. \n                    https:\/\/doi.org\/10.1182\/blood-2010-09-308726","journal-title":"Blood"},{"key":"3517_CR7","doi-asserted-by":"publisher","first-page":"3206","DOI":"10.1182\/blood-2013-06-507962","volume":"122","author":"A Hira","year":"2013","unstructured":"Hira A, Yabe H, Yoshida K et al (2013) Variant ALDH2 is associated with accelerated progression of bone marrow failure in Japanese Fanconi anemia patients. Blood 122:3206\u20133209. \n                    https:\/\/doi.org\/10.1182\/blood-2013-06-507962","journal-title":"Blood"},{"key":"3517_CR8","doi-asserted-by":"publisher","first-page":"457","DOI":"10.1111\/bjh.14243","volume":"175","author":"M Yabe","year":"2016","unstructured":"Yabe M, Yabe H, Morimoto T et al (2016) The phenotype and clinical course of Japanese Fanconi anemia infants is influenced by patient, but not maternal ALDH2 genotype. Br J Haematol 175:457\u2013461. \n                    https:\/\/doi.org\/10.1111\/bjh.14243","journal-title":"Br J Haematol"},{"key":"3517_CR9","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1152\/physrev.00017.2013","volume":"94","author":"CH Chen","year":"2014","unstructured":"Chen CH, Ferreira JC, Gross ER, Mochly-Rosen D (2014) Targeting aldehyde dehaydrogenase 2: new therapeutic opportunities. Physiol Rev 94:1\u201334. \n                    https:\/\/doi.org\/10.1152\/physrev.00017.2013","journal-title":"Physiol Rev"},{"key":"3517_CR10","doi-asserted-by":"publisher","first-page":"2971","DOI":"10.1182\/blood-2016-01-583625","volume":"127","author":"RP Latour de","year":"2016","unstructured":"de Latour RP, Soulier J (2016) How I treat MDS and AML in Fanconi anemia. Blood 127:2971\u20132979. \n                    https:\/\/doi.org\/10.1182\/blood-2016-01-583625","journal-title":"Blood"},{"key":"3517_CR11","doi-asserted-by":"publisher","first-page":"796","DOI":"10.1038\/gim.2016.197","volume":"19","author":"H Muramatsu","year":"2017","unstructured":"Muramatsu H, Okuno Y, Yoshida K et al (2017) Clinical utility of next-generation sequencing for inherited bone marrow failure syndromes. Genet Med 19:796\u2013802. \n                    https:\/\/doi.org\/10.1038\/gim.2016.197","journal-title":"Genet Med"},{"key":"3517_CR12","doi-asserted-by":"publisher","first-page":"1009","DOI":"10.1158\/1055-9965.EPI-05-0911","volume":"15","author":"K Matsuo","year":"2006","unstructured":"Matsuo K, Wakai K, Hirose K, Ito H, Saito T, Tajima K (2006) Alcohol dehydrogenase 2 His47Arg polymorphism influences drinking habit independently of aldehyde dehydrogenase 2 Glu487Lys polymorphism: analysis of 2,299 Japanese subjects. Cancer Epidemiol Biomark Prev 15:1009\u20131013. \n                    https:\/\/doi.org\/10.1158\/1055-9965.EPI-05-0911","journal-title":"Cancer Epidemiol Biomark Prev"},{"key":"3517_CR13","doi-asserted-by":"crossref","first-page":"1650","DOI":"10.1182\/blood.V84.5.1650.1650","volume":"84","author":"A Butturini","year":"1994","unstructured":"Butturini A, Gale RP, Verlander PC, Adler-Brecher B, Gillio AP, Auerbach AD (1994) Hematologic abnormalities in Fanconi anemia: an International Fanconi Anemia Registry study. Blood 84:1650\u20131655","journal-title":"Blood"},{"key":"3517_CR14","doi-asserted-by":"publisher","first-page":"937","DOI":"10.1182\/blood-2009-03-209262","volume":"114","author":"JW Vardiman","year":"2009","unstructured":"Vardiman JW, Thiele J, Arber DA, Brunning RD, Borowitz MJ, Porwit A, Harris NL, le Beau MM, Hellstrom-Lindberg E, Tefferi A, Bloomfield CD (2009) The 2008 revision of the World Health Organization (WHO) classification of myeloid neoplasms and acute leukemia: rationale and important changes. Blood 114:937\u2013951. \n                    https:\/\/doi.org\/10.1182\/blood-2009-03-209262","journal-title":"Blood"},{"key":"3517_CR15","doi-asserted-by":"publisher","first-page":"4791","DOI":"10.1200\/JCO.2008.16.0259","volume":"26","author":"DA Breems","year":"2008","unstructured":"Breems DA, Van Putten WL, De Greef GE et al (2008) Monosomal karyotype in acute myeloid leukemia: a better indicator of poor prognosis than a complex karyotype. J Clin Oncol 26:4791\u20134797. \n                    https:\/\/doi.org\/10.1200\/JCO.2008.16.0259","journal-title":"J Clin Oncol"},{"key":"3517_CR16","doi-asserted-by":"publisher","first-page":"3766","DOI":"10.1182\/blood-2010-04-280313","volume":"116","author":"G G\u00f6hring","year":"2010","unstructured":"G\u00f6hring G, Michalova K, Beverloo HB et al (2010) Complex karyotype newly defined: the strongest prognostic factor in advanced childhood myelodysplastic syndrome. Blood 116:3766\u20133769. \n                    https:\/\/doi.org\/10.1182\/blood-2010-04-280313","journal-title":"Blood"},{"key":"3517_CR17","doi-asserted-by":"publisher","first-page":"666","DOI":"10.1002\/ajh.24373","volume":"91","author":"J Svahn","year":"2016","unstructured":"Svahn J, Bagnasco F, Cappelli E, Onofrillo D, Caruso S, Corsolini F, de Rocco D, Savoia A, Longoni D, Pillon M, Marra N, Ramenghi U, Farruggia P, Locasciulli A, Addari C, Cerri C, Mastrodicasa E, Casazza G, Verzegnassi F, Riccardi F, Haupt R, Barone A, Cesaro S, Cugno C, Dufour C (2016) Somatic, hematologic phenotype, long-term outcome, and effect of hematopoietic stem cell transplantation. An analysis of 97 Fanconi anemia patients from the Italian national database on behalf of the marrow failure study group of the AIEOP (Italian Association of Pediatric Hematology-Oncology). Am J Hematol 91:666\u2013671. \n                    https:\/\/doi.org\/10.1002\/ajh.24373","journal-title":"Am J Hematol"},{"key":"3517_CR18","doi-asserted-by":"crossref","first-page":"1493","DOI":"10.1182\/blood.V95.4.1493.004k35_1493_1498","volume":"95","author":"M Futaki","year":"2000","unstructured":"Futaki M, Yamashita T, Yagasaki H, Toda T, Yabe M, Kato S, Asano S, Nakahata T (2000) The IVS4 + 4 A to T mutation of the Fanconi anemia gene FANCC is not associated with a severe phenotype in Japanese patients. Blood 95:1493\u20131498","journal-title":"Blood"},{"key":"3517_CR19","doi-asserted-by":"publisher","first-page":"1849","DOI":"10.1016\/j.celrep.2014.04.029","volume":"7","author":"Y Huang","year":"2014","unstructured":"Huang Y, Leung JW, Lowery M et al (2014) Modularized functions of the Fanconi anemia core complex. Cell Rep 7:1849\u20131857. \n                    https:\/\/doi.org\/10.1016\/j.celrep.2014.04.029","journal-title":"Cell Rep"},{"key":"3517_CR20","doi-asserted-by":"publisher","first-page":"2867","DOI":"10.1038\/onc.2014.229","volume":"34","author":"B Zhu","year":"2015","unstructured":"Zhu B, Yan K, Li L, Lin M, Zhang S, He Q, Zheng D, Yang H, Shao G (2015) K63-linked ubiquitination of FANCG is required for its association with the Rap80-BRCA1 complex to modulate homologous recombination repair of DNA interstand crosslinks. Oncogene 34:2867\u20132878. \n                    https:\/\/doi.org\/10.1038\/onc.2014.229","journal-title":"Oncogene"},{"key":"3517_CR21","doi-asserted-by":"publisher","first-page":"481","DOI":"10.1002\/humu.20099","volume":"24","author":"H Yagasaki","year":"2004","unstructured":"Yagasaki H, Hamanoue S, Oda T, Nakahata T, Asano S, Yamashita (2004) Identification and characterization of novel mutations of major Fanconi anemia gene FANCA in Japanese population. Hum Mutat 24:481\u2013490. \n                    https:\/\/doi.org\/10.1002\/humu.20099","journal-title":"Hum Mutat"},{"key":"3517_CR22","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1016\/S0165-4608(99)00159-4","volume":"117","author":"BP Alter","year":"2000","unstructured":"Alter BP, Caruso JP, Drachtman RA, Uchida T, Velagaleti GV, Elghetany MT (2000) Fanconi anemia: myelodysplasia as a predictor of outcome. Cancer Genet Cytogenet 117:125\u2013131. \n                    https:\/\/doi.org\/10.1016\/S0165-4608(99)00159-4","journal-title":"Cancer Genet Cytogenet"},{"key":"3517_CR23","doi-asserted-by":"publisher","first-page":"1669","DOI":"10.1200\/JCO.2012.45.9719","volume":"31","author":"M Ayas","year":"2013","unstructured":"Ayas M, Saber W, Davies SM, Harris RE, Hale GA, Socie G, LeRademacher J, Thakar M, Deeg HJJ, al-Seraihy A, Battiwalla M, Camitta BM, Olsson R, Bajwa RS, Bonfim CM, Pasquini R, MacMillan ML, George B, Copelan EA, Wirk B, al Jefri A, Fasth AL, Guinan EC, Horn BN, Lewis VA, Slavin S, Stepensky P, Bierings M, Gale RP (2013) Allogeneic hematopoietic cell transplantation for Fanconi anemia in patients with pretransplantation cytogenetic abnormalities, myelodysplastic syndrome, or acute leukemia. J Clin Oncol 31:1669\u20131676. \n                    https:\/\/doi.org\/10.1200\/JCO.2012.45.9719","journal-title":"J Clin Oncol"},{"key":"3517_CR24","doi-asserted-by":"publisher","first-page":"384","DOI":"10.1111\/bjh.12634","volume":"164","author":"R Mitchell","year":"2014","unstructured":"Mitchell R, Wagner JE, Hirsch B, DeFor TE, Zierhut H, MacMillan ML (2014) Haematopoietic cell transplantation for acute leukaemia and advanced myelodysplastic syndrome in Fanconi anaemia. Br J Haematol 164:384\u2013395. \n                    https:\/\/doi.org\/10.1111\/bjh.12634","journal-title":"Br J Haematol"},{"key":"3517_CR25","doi-asserted-by":"publisher","first-page":"4279","DOI":"10.1182\/blood-2013-01-479733","volume":"122","author":"RP Latour de","year":"2013","unstructured":"de Latour RP, Porcher R, Dalle JH, FA Committee of the Severe Aplastic Anemia Working Party; Pediatric Working Party of the European Group for Blood and Marrow Transplantation et al (2013) Allogeneic hematopoietic stem cell transplantation in Fanconi anemia: the European Group for Blood and Marrow Transplantation experience. Blood 122:4279\u20134286. \n                    https:\/\/doi.org\/10.1182\/blood-2013-01-479733","journal-title":"Blood"},{"key":"3517_CR26","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1111\/bjh.12083","volume":"160","author":"A Yoshimi","year":"2013","unstructured":"Yoshimi A, Niemeyer C, Baumann I, Schwarz-Furlan S, Schindler D, Ebell W, Strahm B (2013) High incidence of Fanconi anaemia in patients with a morphological picture consistent with refractory cytopenia of childhood. Br J Haematol 160:109\u2013111. \n                    https:\/\/doi.org\/10.1111\/bjh.12083","journal-title":"Br J Haematol"},{"key":"3517_CR27","doi-asserted-by":"publisher","first-page":"733","DOI":"10.1007\/s00277-007-0337-z","volume":"86","author":"G G\u00f6hring","year":"2007","unstructured":"G\u00f6hring G, Karow A, Steinemann D, Wilkens L, Lichter P, Zeidler C, Niemeyer C, Welte K, Schlegelberger B (2007) Chromosomal aberrations in congenital bone marrow failure disorders\u2014an early indicator for leukemogenesis? Ann Hematol 86:733\u2013739. \n                    https:\/\/doi.org\/10.1007\/s00277-007-0337-z","journal-title":"Ann Hematol"},{"key":"3517_CR28","doi-asserted-by":"publisher","first-page":"922","DOI":"10.1002\/pbc.24168","volume":"59","author":"A Rochowski","year":"2012","unstructured":"Rochowski A, Olson SB, Alonzo TA, Gerbing RB, Lange BL, Alter BP (2012) Patients with Fanconi anemia and AML have different cytogenetic clones than de novo cases of AML. Pediatr Blood Cancer 59:922\u2013924. \n                    https:\/\/doi.org\/10.1002\/pbc.24168","journal-title":"Pediatr Blood Cancer"},{"key":"3517_CR29","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1309\/AJCP7W9VMJENZOVG","volume":"133","author":"AM Cioc","year":"2010","unstructured":"Cioc AM, Wagner JE, ManMillan ML, DeFor T, Hirsch B (2010) Diagnosis of myelodysplastic syndrome among a cohort of 119 patients with Fanconi anemia: morphologic and cytogenetic characteristics. Am J Clin Pathol 133:92\u2013100. \n                    https:\/\/doi.org\/10.1309\/AJCP7W9VMJENZOVG","journal-title":"Am J Clin Pathol"},{"key":"3517_CR30","doi-asserted-by":"publisher","first-page":"1398","DOI":"10.1182\/blood-2012-04-423046","volume":"120","author":"HJ Deeg","year":"2012","unstructured":"Deeg HJ, Scott BL, Fang M, Shulman HM, Gyurkocza B, Myerson D, Pagel JM, Platzbecker U, Ramakrishnan A, Radich JP, Sandmaier BM, Sorror M, Stirewalt DL, Wilson WA, Storb R, Appelbaum FR, Gooley T (2012) Five-group cytogenetic risk classification, monosomal karyotype, and outcome after hematopoietic cell transplantation for MDS or acute leukemia evolving from MDS. Blood 120:1398\u20131408. \n                    https:\/\/doi.org\/10.1182\/blood-2012-04-423046","journal-title":"Blood"},{"key":"3517_CR31","doi-asserted-by":"publisher","first-page":"2224","DOI":"10.1182\/blood-2010-02-270330","volume":"116","author":"BC Medeiros","year":"2010","unstructured":"Medeiros BC, Othus M, Fang M, Roulston D, Appelbaum FR (2010) Prognostic impact of monosomal karyotype in young adult and elderly acute myeloid leukemia: the southwest oncology group (SWOG) experience. Blood 116:2224\u20132228. \n                    https:\/\/doi.org\/10.1182\/blood-2010-02-270330","journal-title":"Blood"}],"container-title":["Annals of Hematology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00277-018-3517-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00277-018-3517-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00277-018-3517-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,10,26]],"date-time":"2019-10-26T19:26:03Z","timestamp":1572117963000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00277-018-3517-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,10,27]]},"references-count":31,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2019,2]]}},"alternative-id":["3517"],"URL":"https:\/\/doi.org\/10.1007\/s00277-018-3517-0","relation":{},"ISSN":["0939-5555","1432-0584"],"issn-type":[{"value":"0939-5555","type":"print"},{"value":"1432-0584","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,10,27]]},"assertion":[{"value":"28 February 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 October 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 October 2018","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"This study was approved by the Research Ethics Committees of Tokai University and Kyoto University, and all procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and\/or national research committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"Informed consent was obtained from all individual participants included in the study.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}}]}}